Although the detection of the autoantibodies accepted a raise of interest as a tool for diagnosis, early prediction, and monitoring of treatment response of different therapeutic modalities in cancers including breast cancer, PCNA autoantibodies have been seldom reported. Here, PCNA is linked to breast carcinoma.